Anti-inflammatory Effects of Fungal Metabolites in Mouse Intestine as Revealed by In vitro Models

Inflammatory bowel diseases (IBD), which include Crohn's disease and ulcerative colitis, are chronic inflammatory disorders that can affect the whole gastrointestinal tract or the colonic mucosal layer. Current therapies aiming to suppress the exaggerated immune response in IBD largely rely on...

Full description

Bibliographic Details
Main Authors: Dominik Schreiber, Lisa Marx, Silke Felix, Jasmin Clasohm, Maximilian Weyland, Maximilian Schäfer, Markus Klotz, Rainer Lilischkis, Gerhard Erkel, Karl-Herbert Schäfer
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-08-01
Series:Frontiers in Physiology
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fphys.2017.00566/full
_version_ 1818948811474599936
author Dominik Schreiber
Dominik Schreiber
Lisa Marx
Silke Felix
Jasmin Clasohm
Maximilian Weyland
Maximilian Schäfer
Markus Klotz
Rainer Lilischkis
Gerhard Erkel
Karl-Herbert Schäfer
Karl-Herbert Schäfer
author_facet Dominik Schreiber
Dominik Schreiber
Lisa Marx
Silke Felix
Jasmin Clasohm
Maximilian Weyland
Maximilian Schäfer
Markus Klotz
Rainer Lilischkis
Gerhard Erkel
Karl-Herbert Schäfer
Karl-Herbert Schäfer
author_sort Dominik Schreiber
collection DOAJ
description Inflammatory bowel diseases (IBD), which include Crohn's disease and ulcerative colitis, are chronic inflammatory disorders that can affect the whole gastrointestinal tract or the colonic mucosal layer. Current therapies aiming to suppress the exaggerated immune response in IBD largely rely on compounds with non-satisfying effects or side-effects. Therefore, new therapeutical options are needed. In the present study, we investigated the anti-inflammatory effects of the fungal metabolites, galiellalactone, and dehydrocurvularin in both an in vitro intestinal inflammation model, as well as in isolated myenteric plexus and enterocyte cells. Administration of a pro-inflammatory cytokine mix through the mesenteric artery of intestinal segments caused an up-regulation of inflammatory marker genes. Treatment of the murine intestinal segments with galiellalactone or dehydrocurvularin by application through the mesenteric artery significantly prevented the expression of pro-inflammatory marker genes on the mRNA and the protein level. Comparable to the results in the perfused intestine model, treatment of primary enteric nervous system (ENS) cells from the murine intestine with the fungal compounds reduced expression of cytokines such as IL-6, TNF-α, IL-1β, and inflammatory enzymes such as COX-2 and iNOS on mRNA and protein levels. Similar anti-inflammatory effects of the fungal metabolites were observed in the human colorectal adenocarcinoma cell line DLD-1 after stimulation with IFN-γ (10 ng/ml), TNF-α (10 ng/ml), and IL-1β (5 ng/ml). Our results show that the mesenterially perfused intestine model provides a reliable tool for the screening of new therapeutics with limited amounts of test compounds. Furthermore, we could characterize the anti-inflammatory effects of two novel active compounds, galiellalactone, and dehydrocurvularin which are interesting candidates for studies with chronic animal models of IBD.
first_indexed 2024-12-20T08:52:44Z
format Article
id doaj.art-05ae6787b8734e10b322bdfecbccdc7a
institution Directory Open Access Journal
issn 1664-042X
language English
last_indexed 2024-12-20T08:52:44Z
publishDate 2017-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Physiology
spelling doaj.art-05ae6787b8734e10b322bdfecbccdc7a2022-12-21T19:46:05ZengFrontiers Media S.A.Frontiers in Physiology1664-042X2017-08-01810.3389/fphys.2017.00566283634Anti-inflammatory Effects of Fungal Metabolites in Mouse Intestine as Revealed by In vitro ModelsDominik Schreiber0Dominik Schreiber1Lisa Marx2Silke Felix3Jasmin Clasohm4Maximilian Weyland5Maximilian Schäfer6Markus Klotz7Rainer Lilischkis8Gerhard Erkel9Karl-Herbert Schäfer10Karl-Herbert Schäfer11Department of Biotechnology, University of Applied Sciences KaiserslauternKaiserslautern, GermanyDepartment of Biotechnology, Technical University of KaiserslauternKaiserslautern, GermanyDepartment of Biotechnology, University of Applied Sciences KaiserslauternKaiserslautern, GermanyDepartment of Biotechnology, Technical University of KaiserslauternKaiserslautern, GermanyDepartment of Biotechnology, University of Applied Sciences KaiserslauternKaiserslautern, GermanyDepartment of Biotechnology, University of Applied Sciences KaiserslauternKaiserslautern, GermanyDepartment of Biotechnology, University of Applied Sciences KaiserslauternKaiserslautern, GermanyDepartment of Biotechnology, University of Applied Sciences KaiserslauternKaiserslautern, GermanyDepartment of Biotechnology, University of Applied Sciences KaiserslauternKaiserslautern, GermanyDepartment of Biotechnology, Technical University of KaiserslauternKaiserslautern, GermanyDepartment of Biotechnology, University of Applied Sciences KaiserslauternKaiserslautern, GermanyPediatric Surgery, University Hospital MannheimMannheim, GermanyInflammatory bowel diseases (IBD), which include Crohn's disease and ulcerative colitis, are chronic inflammatory disorders that can affect the whole gastrointestinal tract or the colonic mucosal layer. Current therapies aiming to suppress the exaggerated immune response in IBD largely rely on compounds with non-satisfying effects or side-effects. Therefore, new therapeutical options are needed. In the present study, we investigated the anti-inflammatory effects of the fungal metabolites, galiellalactone, and dehydrocurvularin in both an in vitro intestinal inflammation model, as well as in isolated myenteric plexus and enterocyte cells. Administration of a pro-inflammatory cytokine mix through the mesenteric artery of intestinal segments caused an up-regulation of inflammatory marker genes. Treatment of the murine intestinal segments with galiellalactone or dehydrocurvularin by application through the mesenteric artery significantly prevented the expression of pro-inflammatory marker genes on the mRNA and the protein level. Comparable to the results in the perfused intestine model, treatment of primary enteric nervous system (ENS) cells from the murine intestine with the fungal compounds reduced expression of cytokines such as IL-6, TNF-α, IL-1β, and inflammatory enzymes such as COX-2 and iNOS on mRNA and protein levels. Similar anti-inflammatory effects of the fungal metabolites were observed in the human colorectal adenocarcinoma cell line DLD-1 after stimulation with IFN-γ (10 ng/ml), TNF-α (10 ng/ml), and IL-1β (5 ng/ml). Our results show that the mesenterially perfused intestine model provides a reliable tool for the screening of new therapeutics with limited amounts of test compounds. Furthermore, we could characterize the anti-inflammatory effects of two novel active compounds, galiellalactone, and dehydrocurvularin which are interesting candidates for studies with chronic animal models of IBD.http://journal.frontiersin.org/article/10.3389/fphys.2017.00566/fullinflammatory bowel diseasemesenterial perfusiongaliellalactonedehydrocurvularindexamethasoneENS
spellingShingle Dominik Schreiber
Dominik Schreiber
Lisa Marx
Silke Felix
Jasmin Clasohm
Maximilian Weyland
Maximilian Schäfer
Markus Klotz
Rainer Lilischkis
Gerhard Erkel
Karl-Herbert Schäfer
Karl-Herbert Schäfer
Anti-inflammatory Effects of Fungal Metabolites in Mouse Intestine as Revealed by In vitro Models
Frontiers in Physiology
inflammatory bowel disease
mesenterial perfusion
galiellalactone
dehydrocurvularin
dexamethasone
ENS
title Anti-inflammatory Effects of Fungal Metabolites in Mouse Intestine as Revealed by In vitro Models
title_full Anti-inflammatory Effects of Fungal Metabolites in Mouse Intestine as Revealed by In vitro Models
title_fullStr Anti-inflammatory Effects of Fungal Metabolites in Mouse Intestine as Revealed by In vitro Models
title_full_unstemmed Anti-inflammatory Effects of Fungal Metabolites in Mouse Intestine as Revealed by In vitro Models
title_short Anti-inflammatory Effects of Fungal Metabolites in Mouse Intestine as Revealed by In vitro Models
title_sort anti inflammatory effects of fungal metabolites in mouse intestine as revealed by in vitro models
topic inflammatory bowel disease
mesenterial perfusion
galiellalactone
dehydrocurvularin
dexamethasone
ENS
url http://journal.frontiersin.org/article/10.3389/fphys.2017.00566/full
work_keys_str_mv AT dominikschreiber antiinflammatoryeffectsoffungalmetabolitesinmouseintestineasrevealedbyinvitromodels
AT dominikschreiber antiinflammatoryeffectsoffungalmetabolitesinmouseintestineasrevealedbyinvitromodels
AT lisamarx antiinflammatoryeffectsoffungalmetabolitesinmouseintestineasrevealedbyinvitromodels
AT silkefelix antiinflammatoryeffectsoffungalmetabolitesinmouseintestineasrevealedbyinvitromodels
AT jasminclasohm antiinflammatoryeffectsoffungalmetabolitesinmouseintestineasrevealedbyinvitromodels
AT maximilianweyland antiinflammatoryeffectsoffungalmetabolitesinmouseintestineasrevealedbyinvitromodels
AT maximilianschafer antiinflammatoryeffectsoffungalmetabolitesinmouseintestineasrevealedbyinvitromodels
AT markusklotz antiinflammatoryeffectsoffungalmetabolitesinmouseintestineasrevealedbyinvitromodels
AT rainerlilischkis antiinflammatoryeffectsoffungalmetabolitesinmouseintestineasrevealedbyinvitromodels
AT gerharderkel antiinflammatoryeffectsoffungalmetabolitesinmouseintestineasrevealedbyinvitromodels
AT karlherbertschafer antiinflammatoryeffectsoffungalmetabolitesinmouseintestineasrevealedbyinvitromodels
AT karlherbertschafer antiinflammatoryeffectsoffungalmetabolitesinmouseintestineasrevealedbyinvitromodels